Answers are grounded in this paper and cite their sources.
Framework demonstrates potential for HIV-1 eradication using thermodynamic targeting and resistance mutation analysis.
Current HIV therapeutics target biological features that evolution can modify, explaining why 30+ antiretroviral drugs achieve suppression but not cure. We propose a physics-based framework that exploits high-barrier thermodynamic constraints—regions where mutations impose severe fitness costs on the virus. Our approach comprises three integrated components: (1) The Entropic Vise, targeting the gp41 HR1 domain (HXB2 residues 546-556) which exhibits near-zero Shannon entropy across 500,000+ sequences, indicating strong purifying selection; (2) Thermodynamically Constrained Generative Models that predict future variants; and (3) Sentinel Cells engineered with humanized reporters (ΔNGFR) for real-time latency detection. While clinical data from Enfuvirtide demonstrate that resistance mutations can emerge under selective pressure, these escape mutants exhibit significant fitness costs. This framework proposes high-barrier targeting as a testable hypothesis for complementary therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Rhine Lesther Tague (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: